3[18]Yamashita M, Matsuda M, Mori T. In Situ Detection of Prolactin Receptor mRNA and Apoptotic Cell Death in Mouse Uterine Tissues with Adenomyosis. In Vivo, 1999, 13:57-60
4[19]Umesaki N, Tanaka T, Miyama M, et al. Increased natural killer cell activities in patients treated with gonadotropin releasing hormone agonist.Gynecol Obstet Invest, 1999, 48:66 - 68
5[20]Cohen I, Shapita J, Beyth Y, et al. Estrogen and progesterone receptors of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Invest, 1998, 45: 126-131
6[21]Konopka B, Skasko E, Kluska A, et al. Changes in the concentrations of receptors of insulin - like growth factor - Ⅰ, epithelial growth factor,oestrogens and progestagens in adenomyosis foci, endometrium and myometrium of women during menstrual cycle. Eur J Gynaenol Oncol, 1998,19:93-97
7[22]Kitawaki J, Kusuki I, Koshiba H, et al. Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis. Gynecol Ob. stet Invest,1999,48 (Suppl): 121 -128
8[23]Kitawaki J, Noguchi T, Amatsu T, et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod, 1997, 57:514-519
9[24]Yamamoto T, Noguchi T, Tamura T, et al. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol, 1993, 169: 734-738
10[25]Kitawaki J, Kusuki I, Koshiba H, et al. Detection of aromatase cytochrome P- 450 as a diagnostic test for endometriosis. Fertil Steril,1999, 72: 1100-1106
